Pictet Asset Management
RCKT icon

Pictet Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Pictet Asset Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,317,969
Closed -$8.79M – 2045
2025
Q1 		$8.79M Hold
1,317,969
– – 0.01% 691
2024
Q4 		$16.6M Sell
1,317,969
-68,736
-5% -$1.03M 0.02% 555
2024
Q3 		$25.6M Buy
1,386,705
+160,318
+13% +$3.28M 0.03% 419
2024
Q2 		$26.4M Sell
1,226,387
-97,060
-7% -$2.23M 0.03% 400
2024
Q1 		$35.7M Sell
1,323,447
-23,716
-2% -$674K 0.04% 367
2023
Q4 		$40.4M Buy
+1,347,163
New +$29.7M 0.04% 344

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Pictet Asset Management's RCKT Position: Q2 2025 in Review

Pictet Asset Management sold out of Rocket Pharmaceuticals (RCKT) in Q2 2025, closing a stake of 1,317,969 shares — an estimated $8.79M sold.

Pictet Asset Management first reported a position in RCKT in Q4 2023 and held it in 6 quarters. The position peaked at $40.4M in Q4 2023. 196 funds tracked by Wall St. Rank hold RCKT as of Q2 2025.

  • Pictet Asset Management reported no remaining Rocket Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Pictet Asset Management sold 1,317,969 Rocket Pharmaceuticals shares in Q2 2025, an estimated $8.79M.
  • Pictet Asset Management first reported a position in Rocket Pharmaceuticals in Q4 2023 and held it in 6 quarters.
  • Pictet Asset Management's Rocket Pharmaceuticals position peaked at $40.4M in Q4 2023.
  • 196 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2025.

Based on Pictet Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.